Literature DB >> 26804631

[Formula: see text]Introducing a forced-choice recognition task to the California Verbal Learning Test - Children's Version.

Jonathan D Lichtenstein1, Laszlo A Erdodi2, Kate S Linnea1.   

Abstract

The importance of performance validity tests (PVTs) is increasingly recognized in pediatric neuropsychology. To date, research has focused on investigating whether PVTs designed for adults function similarly in children. The downward extension of adult cutoffs is counter-intuitive considering the robust effect of age-related changes in basic cognitive skills in children and adolescents. The purpose of this study was to examine the signal detection properties of a forced-choice recognition trial (FCR-C) for the California Verbal Learning Test - Children's Version. A total of 72 children aged 6-15 years (M = 11.1 , SD = 2.6) completed the FCR-C as part of a larger neuropsychological assessment battery. Cross-validation analyses revealed that the FCR-C had good signal detection performance against reference PVTs. The first level of failure (≤14/15) produced the best combination of overall sensitivity (.31) and specificity (.87). A more conservative FCR-C cutoff (≤13) resulted in a predictable trade-off between sensitivity (.15) and specificity (.94), but also a net loss in discriminant power. Lowering the cutoff to ≤12 resulted in a slight improvement in specificity (.97) but further deterioration in sensitivity (.14). These preliminary findings suggest that the FCR-C has the potential to become the newest addition to a growing arsenal of pediatric PVTs.

Entities:  

Keywords:  CVLT-C; effort testing; embedded validity indicators; pediatric PVTs; performance validity testing

Mesh:

Year:  2016        PMID: 26804631     DOI: 10.1080/09297049.2015.1135422

Source DB:  PubMed          Journal:  Child Neuropsychol        ISSN: 0929-7049            Impact factor:   2.500


  1 in total

1.  Prevalence of Invalid Performance on Baseline Testing for Sport-Related Concussion by Age and Validity Indicator.

Authors:  Christopher A Abeare; Isabelle Messa; Brandon G Zuccato; Bradley Merker; Laszlo Erdodi
Journal:  JAMA Neurol       Date:  2018-06-01       Impact factor: 18.302

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.